Literature DB >> 24786725

Characteristics of a large cohort of patients with diabetes having at-risk feet and outcomes in patients with foot ulceration referred to a tertiary care diabetes unit.

Musarrat Riaz1, Zahid Miyan1, Syed I Zaidi2, Syed Fd Alvi3, Asher Fawwad3, Muhammad Y Ahmadani1, Asim B Zafar1, Rayaz A Malik4, Abdul Basit5.   

Abstract

To identify in a large population cohort the clinical and biochemical characteristics of patients with diabetes at risk of foot ulceration and outcomes in those with foot ulcers. All patients with diabetes attending Baqai Institute of Diabetology and Endocrinology from January 2004 to April 2012 included in the study. Clinical, biochemical and socio-demographic data were collected and patients were categorised into those at no risk of ulceration, at risk of ulceration and those with foot ulcer, according to the University of Texas classification. Patients with foot ulceration followed for their final outcome, that is complete healing, persisted non-healed ulcer, lower extremity amputation, lost to follow-up or death. A total of 18 119 patients with diabetes underwent assessment, 3576 (19·7%) patients defined as at high risk for foot ulceration and 3731 (20·6%) presented with foot ulcer. Age, male gender, hypertension, higher glycated haemoglobin (HbA1c), history of smoking and presence of neuropathy were risk factors (P < 0·000) for foot ulceration. Amputation rate in patients with foot ulceration was significantly related to severity of ulceration at presentation. Preventive foot care practices were followed by 19·02% patients. One thousand eight hundred seventy three (50·2%) patients completely healed, 293 (11%) patients underwent amputation and 397 (10·1%) patients continued to be treated in the foot clinic. All patients with diabetes should be screened for neuropathy to identify those at risk of foot ulceration, as it is the major contributory factor for foot ulceration. The final outcome of foot ulceration was determined by the severity and grade of ulcer at presentation.
© 2014 The Authors. International Wound Journal © 2014 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Amputation; Diabetic foot; Feet at risk; Foot ulcer

Mesh:

Year:  2014        PMID: 24786725      PMCID: PMC7949534          DOI: 10.1111/iwj.12289

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  22 in total

1.  Diabetic foot ulcer--a prospective study.

Authors:  S M Ali; A Basit; T Sheikh; S Mumtaz; M Z Hydrie
Journal:  J Pak Med Assoc       Date:  2001-02       Impact factor: 0.781

Review 2.  Amputations and ulceration; pitfalls in assessing incidence.

Authors:  William H van Houtum
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

Review 3.  The diabetic foot in the developing world.

Authors:  Nigel Unwin
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

4.  A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.

Authors:  E J Boyko; J H Ahroni; V Stensel; R C Forsberg; D R Davignon; D G Smith
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

Review 5.  What is the most effective way to reduce incidence of amputation in the diabetic foot?

Authors:  J Apelqvist; J Larsson
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

6.  Risks to feet in the top end: outcomes of diabetic foot complications.

Authors:  Ian O'Rourke; Sam Heard; John Treacy; Russell Gruen; Cherie Whitbread
Journal:  ANZ J Surg       Date:  2002-04       Impact factor: 1.872

7.  Classification of diabetic foot wounds.

Authors:  L A Lavery; D G Armstrong; L B Harkless
Journal:  J Foot Ankle Surg       Date:  1996 Nov-Dec       Impact factor: 1.286

8.  The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

Authors:  C A Abbott; A L Carrington; H Ashe; S Bath; L C Every; J Griffiths; A W Hann; A Hussein; N Jackson; K E Johnson; C H Ryder; R Torkington; E R E Van Ross; A M Whalley; P Widdows; S Williamson; A J M Boulton
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

9.  Evaluation and management of diabetic foot according to Wagner's classification. A study of 100 cases.

Authors:  Mukhtar Ahmed; Samson Griffin
Journal:  J Ayub Med Coll Abbottabad       Date:  2003 Jul-Sep

10.  Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study.

Authors:  Edouard Ghanassia; Laetitia Villon; Jean-François Thuan Dit Dieudonné; Catherine Boegner; Antoine Avignon; Ariane Sultan
Journal:  Diabetes Care       Date:  2008-04-04       Impact factor: 19.112

View more
  4 in total

1.  Risk factors for major amputation in hospitalised diabetic foot patients.

Authors:  Sik Namgoong; Suyoung Jung; Seung-Kyu Han; Seong-Ho Jeong; Eun-Sang Dhong; Woo-Kyung Kim
Journal:  Int Wound J       Date:  2015-10-19       Impact factor: 3.315

2.  Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year.

Authors:  Michael H Carstens; Francisco J Quintana; Santos T Calderwood; Juan P Sevilla; Arlen B Ríos; Carlos M Rivera; Dorian W Calero; María L Zelaya; Nelson Garcia; Kenneth A Bertram; Joseph Rigdon; Severiano Dos-Anjos; Diego Correa
Journal:  Stem Cells Transl Med       Date:  2021-04-07       Impact factor: 6.940

3.  Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)-Two-Year Follow-Up Study.

Authors:  Leila Yazdanpanah; Hajieh Shahbazian; Iraj Nazari; Hamid Reza Arti; Fatemeh Ahmadi; Seyed Ehsan Mohammadianinejad; Bahman Cheraghian; Saeed Hesam
Journal:  Int J Endocrinol       Date:  2018-03-15       Impact factor: 3.257

4.  Strong association of anemia in people with diabetic foot ulcers (DFUs): Study from a specialist foot care center.

Authors:  Abdul Majid Shareef; Muhammad Yakoob Ahmedani; Nazish Waris
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.